These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9245064)

  • 1. [Successful gamma globulin therapy in a patient with anti-IgA antibodies].
    Litzman J; Broz P; Král V; Lokaj J
    Vnitr Lek; 1997 Feb; 43(2):102-4. PubMed ID: 9245064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy.
    Eijkhout HW; van den Broek PJ; van der Meer JW
    Neth J Med; 2003 Jun; 61(6):213-7. PubMed ID: 12948165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
    Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.
    de Albuquerque Campos R; Sato MN; da Silva Duarte AJ
    J Clin Immunol; 2000 Jan; 20(1):77-82. PubMed ID: 10798611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is there any clinical significance to anti-IgA antibodies which appear in patients with immunodeficiencies treated with intravenous gamma globulin?].
    Ferreira A; Cruz García Rodríguez M; Martín J; Fontán G
    Sangre (Barc); 1995 Jun; 40(3):171-3. PubMed ID: 7570266
    [No Abstract]   [Full Text] [Related]  

  • 7. A new strategy for the prevention of IgA anaphylactic transfusion reactions.
    Salama A; Temmesfeld B; Hippenstiel S; Kalus U; Suttorp N; Kiesewetter H
    Transfusion; 2004 Apr; 44(4):509-11. PubMed ID: 15043565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.
    Ahrens N; Höflich C; Bombard S; Lochs H; Kiesewetter H; Salama A
    Clin Exp Immunol; 2008 Mar; 151(3):455-8. PubMed ID: 18234056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin.
    Frankel SJ; Polmar SH; Grumet FC; Wedner HJ
    Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.
    Schaffer FM; Newton JA
    J Perinatol; 1994; 14(2):114-7. PubMed ID: 8014693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.
    Cunningham-Rundles C; Zhou Z; Mankarious S; Courter S
    J Clin Immunol; 1993 Jul; 13(4):272-8. PubMed ID: 8227286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of human gamma globulin in the treatment of common variable immunodeficiency].
    de Gracia J; Vendrell M; Guarner L; Vidal R; Miravitlles M; Mayordomo C; Morell F
    Med Clin (Barc); 1995 Feb; 104(6):201-6. PubMed ID: 7534366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin.
    Bayry J; Lacroix-Desmazes S; Hermine O; Oksenhendler E; Kazatchkine MD; Kaveri SV
    Am J Med; 2005 Dec; 118(12):1439-40. PubMed ID: 16378810
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin.
    Palmeira P; Costa-Carvalho BT; Arslanian C; Pontes GN; Nagao AT; Carneiro-Sampaio MM
    Pediatr Allergy Immunol; 2009 Sep; 20(6):528-35. PubMed ID: 19220771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Common variable immunodeficiency in adults and problems of its immunotherapy].
    Borisova AM; Setdikova NKh; Kaliazina VA; Malashenkova EV; Varfolomeeva MI
    Ter Arkh; 1998; 70(5):14-20. PubMed ID: 9644735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variable immunodeficiency.
    de Almeida Barry LR; Forte WC
    Allergol Immunopathol (Madr); 2004; 32(2):89-91. PubMed ID: 15087097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
    Moore ML; Quinn JM
    Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.
    Lucas M; Lee M; Lortan J; Lopez-Granados E; Misbah S; Chapel H
    J Allergy Clin Immunol; 2010 Jun; 125(6):1354-1360.e4. PubMed ID: 20471071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon conundrum in common variable immunodeficiency.
    Cunningham-Rundles C; Routes JM; Hostoffer R; Sullivan KE
    Clin Immunol; 2005 Sep; 116(3):208-10. PubMed ID: 15905130
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined immunodeficiency (CID) with oligoclonal gammopathy.
    Davies EG; Sharland M; Kaminski E; Nisbet J; Periera RS
    Immunodeficiency; 1993; 4(1-4):67-9. PubMed ID: 8167737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.